{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:52:23Z","timestamp":1782121943494,"version":"3.54.5"},"reference-count":40,"publisher":"BMJ","issue":"7","funder":[{"name":"University of Melbourne Research Training Program Scholarship"},{"name":"National Health and Medical Research Council Investigator Grant","award":["NHMRC GNT1194694"],"award-info":[{"award-number":["NHMRC GNT1194694"]}]},{"name":"Raine Foundation Clinician Researcher Fellowship"},{"name":"Melbourne Children\u2019s Postgraduate Research Scholarship"},{"name":"National Health and Medical Research Council of Australia","award":["NHMRC APP2033152"],"award-info":[{"award-number":["NHMRC APP2033152"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2026,2,20]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the incidence, serotype distribution and clinical outcomes of invasive pneumococcal disease (IPD) in children with acute lymphoblastic leukaemia (ALL) following widespread use of pneumococcal conjugate vaccines (PCVs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two tertiary paediatric oncology centres in Australia\u2014Royal Children\u2019s Hospital\u2014Melbourne and Perth Children\u2019s Hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Children with cancer, including a defined subgroup with ALL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>All children were assessed for provision of pneumococcal vaccines before and after their diagnosis of cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Incidence of IPD in cancer (ALL and non-ALL) compared with the general paediatric population, serotype distribution, vaccination status and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 29 episodes of IPD in 28 children with cancer were included, of whom 19 had ALL. Less than a quarter had received additional pneumococcal vaccinations beyond the standard PCV schedule. The incidence of IPD in children with ALL was 190\u2013360 times higher than in healthy children (1360 per 100 000 person-years). The majority of episodes (83%) were due to non-PCV13 serotypes, most commonly 23B. Clinical presentation was predominantly bacteraemia. Most patients recovered within 30 days, but there was one death attributable to IPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with ALL remain at substantially increased risk of IPD despite widespread PCV use, with disease largely caused by non-PCV13 serotypes. Uptake of additional pneumococcal doses was low. These findings underscore the need for optimised vaccination and prophylactic strategies in paediatric oncology populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2025-329609","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:20:20Z","timestamp":1772734820000},"page":"631-637","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive pneumococcal disease in children with acute lymphoblastic leukaemia"],"prefix":"10.1136","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-0771","authenticated-orcid":false,"given":"Linny Kimly","family":"Phuong","sequence":"first","affiliation":[{"name":"Infection & Immunity Theme Group, Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Infection & Immunity Theme Group, Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Infectious Diseases, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Blyth","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Nedlands, Western Australia, Australia"},{"name":"School of Medicine and Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute, University of Western Australia, Nedlands, Western Australia, Australia"},{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Theophillia","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Infection & Immunity Theme Group, Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hanna","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Centre, Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi S","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children\u2019s Hospital, Nedlands, Western Australia, Australia"},{"name":"Leukaemia Translational Research Laboratory, WA Kids Cancer Centre, The Kids Research Institute, University of Western Australia, Nedlands, Western Australia, Australia"},{"name":"Curtin Medical School, Curtin University, Bentley, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-612X","authenticated-orcid":false,"given":"Daniel K","family":"Yeoh","sequence":"additional","affiliation":[{"name":"Infection & Immunity Theme Group, Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Nedlands, Western Australia, Australia"},{"name":"School of Medicine and Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute, University of Western Australia, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026062202301065000_111.7.631.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.12.043"},{"key":"2026062202301065000_111.7.631.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06601.x"},{"key":"2026062202301065000_111.7.631.3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-12"},{"key":"2026062202301065000_111.7.631.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ803"},{"key":"2026062202301065000_111.7.631.5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamapediatrics.2019.3203","article-title":"Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era: A Systematic Review","volume":"173","author":"Butters","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2026062202301065000_111.7.631.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1510"},{"key":"2026062202301065000_111.7.631.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07903.x"},{"key":"2026062202301065000_111.7.631.8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw720"},{"key":"2026062202301065000_111.7.631.9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2063"},{"key":"2026062202301065000_111.7.631.10","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181eaf89a"},{"key":"2026062202301065000_111.7.631.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00665-0"},{"key":"2026062202301065000_111.7.631.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30052-5"},{"key":"2026062202301065000_111.7.631.13","unstructured":"Australian Government- Department of Health DaA . Current coverage data tables for all children. 2025. Available: https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-data\/childhood-immunisation-coverage\/current-coverage-data-tables-for-all-children"},{"key":"2026062202301065000_111.7.631.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.02.017"},{"key":"2026062202301065000_111.7.631.15","doi-asserted-by":"crossref","first-page":"106490","DOI":"10.1016\/j.jinf.2025.106490","article-title":"Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006\/07-2017\/18","volume":"90","author":"Bertran","year":"2025","journal-title":"J Infect"},{"key":"2026062202301065000_111.7.631.16","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI) . Australian immunisation handbook. 2024. Available: https:\/\/immunisationhandbook.health.gov.au\/"},{"key":"2026062202301065000_111.7.631.17","unstructured":"National notifiable diseases surveillance system (NNDSS) public dataset (2009- 2022)\u2013 pneumococcal disease (invasive). 2023."},{"key":"2026062202301065000_111.7.631.18","unstructured":"Commonwealth of Australia- Australian Bureau of Statistics . Population by age and sex - national. Available: https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/dec-2024 [Accessed 9 Jul 2025]."},{"key":"2026062202301065000_111.7.631.19","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268810000919"},{"key":"2026062202301065000_111.7.631.20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/23744235.2015.1115894","article-title":"Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland","volume":"48","author":"Lindstr\u00f6m","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"2026062202301065000_111.7.631.21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/21645515.2015.1072666","article-title":"Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine","volume":"12","author":"Principi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2026062202301065000_111.7.631.22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00441492","article-title":"Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood","volume":"139","author":"de Vaan","year":"1982","journal-title":"Eur J Pediatr"},{"key":"2026062202301065000_111.7.631.23","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199809000-00008"},{"key":"2026062202301065000_111.7.631.24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.6.e91","article-title":"Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens","volume":"109","author":"Nilsson","year":"2002","journal-title":"Pediatrics"},{"key":"2026062202301065000_111.7.631.25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28565","article-title":"Vaccination in pediatric cancer survivors: Vaccination rates, immune status, and knowledge regarding compliance","volume":"67","author":"Choi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2026062202301065000_111.7.631.26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/apa.17070","article-title":"Adequate immune responses to vaccines after chemotherapy for leukaemia diagnosed in childhood","volume":"113","author":"\u00d3skarsson","year":"2024","journal-title":"Acta Paediatr"},{"key":"2026062202301065000_111.7.631.27","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1093\/cid\/ciaa163","article-title":"Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study","volume":"71","author":"Top","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026062202301065000_111.7.631.28","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000502"},{"key":"2026062202301065000_111.7.631.29","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28944","article-title":"Pneumococcal vaccination during chemotherapy in children treated for acute lymphoblastic leukemia","volume":"68","author":"Dorval","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2026062202301065000_111.7.631.30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijid.2021.03.072","article-title":"Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study","volume":"106","author":"Garcia Garrido","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026062202301065000_111.7.631.31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eimc.2016.09.003","article-title":"Adapting immunisation schedules for children undergoing chemotherapy. enferm infecc microbiol clin","volume":"36","author":"Fern\u00e1ndez-Prada","year":"2018","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"2026062202301065000_111.7.631.32","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu052.782","article-title":"1074Immunization Practices of Pediatric Oncology Providers Towards Children with Acute Lymphoblastic Leukemia that have Completed Chemotherapy","volume":"1","author":"Sulieman","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"2026062202301065000_111.7.631.33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/21645515.2015.1115165","article-title":"Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology\/Oncology centers","volume":"12","author":"Top","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2026062202301065000_111.7.631.34","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae220","article-title":"Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities","volume":"11","author":"Feemster","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026062202301065000_111.7.631.35","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/cncr.30764","article-title":"Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients","volume":"123","author":"Hung","year":"2017","journal-title":"Cancer"},{"key":"2026062202301065000_111.7.631.36","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","volume":"3","author":"Rankine-Mullings","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026062202301065000_111.7.631.37","first-page":"546","article-title":"Infections in sickle cell disease","volume":"110","author":"Scourfield","year":"2025","journal-title":"Haematologica"},{"key":"2026062202301065000_111.7.631.38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.autrev.2019.03.010","article-title":"Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review","volume":"18","author":"Wijetilleka","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2026062202301065000_111.7.631.39","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.64","article-title":"Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia","volume":"4","author":"Zugmaier","year":"2014","journal-title":"Blood Cancer J"},{"key":"2026062202301065000_111.7.631.40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/08880018.2022.2049936","article-title":"Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immunoglobulin production","volume":"39","author":"Essa","year":"2022","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2025-329609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:36:00Z","timestamp":1782120960000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2025-329609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/archdischild-2025-329609"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2025-329609","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}